Gene Amplification and Increased Expression of the Reduced Folate Carrier in Transport Elevated K562 Cells

The molecular bases for the 6-fold elevated methotrexate transport capacity of K562.4CF cells (Matherly et al., Cancer Res. 51: 3420–3426, 1991) were studied with reduced folate carrier (RFC) cDNA, genomic, and antibody probes. Southern analysis showed that RFC gene copies were increased (≈4- to 5-f...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 55; no. 7; pp. 1135 - 1138
Main Authors Wong, So C, Zhang, Long, Proefke, Susan A, Hukku, Bharati, Matherly, Larry H
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.1998
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The molecular bases for the 6-fold elevated methotrexate transport capacity of K562.4CF cells (Matherly et al., Cancer Res. 51: 3420–3426, 1991) were studied with reduced folate carrier (RFC) cDNA, genomic, and antibody probes. Southern analysis showed that RFC gene copies were increased (≈4- to 5-fold) in K562.4CF over wild-type K562 cells. Fluorescence in situ hybridization using a genomic RFC probe confirmed the localization of the RFC gene to the q-arm of chromosome 21. In K562.4CF cells, the frequent loss of a normal copy of chromosome 21 (61% of metaphases) was accompanied by RFC gene amplification and translocations of amplified RFC gene fragments to several (2 to 6) different chromosomal loci not seen in wild-type cells. Particularly intense RFC signals were mapped to homogeneously staining regions in chromosomes 2 and 15. Increased RFC gene copies were accompanied by a similar increase in the major 3.1 kb RFC transcript by northern blotting and an ≈7-fold elevated level of the broadly migrating (80–95 kDa) RFC protein on a western blot probed with an RFC C-terminal peptide antibody. These results demonstrate that selection of cells with a growth-limiting concentration of reduced folates (0.4 nM of leucovorin) is sufficient to promote chromosomal aberrations, including gene amplification and translocations that result in increased RFC expression and folate transport.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-2952
1873-2968
DOI:10.1016/S0006-2952(97)00639-4